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h i g h l i g h t s
 Global states underlying Huntington’s disease (HD): reduced connectivity and severity related dimen-
sionality increase.
 Microstates in HD: classes A & B more prominent, classes C & D less prominent.
 Cognitive test scores related to global- and microstate properties.
a b s t r a c t
Objective: Huntington’s disease (HD) is characterized by psychiatric, cognitive, and motor disturbances.
The study aimed to determine electroencephalography (EEG) global state and microstate changes in
HD and their relationship with cognitive and behavioral impairments.
Methods: EEGs from 20 unmedicated HD patients and 20 controls were compared using global state
properties (connectivity and dimensionality) and microstate properties (EEG microstate analysis). For
four microstate classes (A, B, C, D), three parameters were computed: duration, occurrence, coverage.
Global- and microstate properties were compared between groups and correlated with cognitive test
scores for patients.
Results: Global state analysis showed reduced connectivity in HD and an increasing dimensionality with
increasing HD severity. Microstate analysis revealed parameter increases for classes A and B (coverage),
decreases for C (occurrence) and D (coverage and occurrence). Disease severity and poorer test perfor-
mances correlated with parameter increases for class A (coverage and occurrence), decreases for C (cov-
erage and duration) and a dimensionality increase.
Conclusions: Global state changes may reflect higher functional dissociation between brain areas and the
complex microstate changes possibly the widespread neuronal death and corresponding functional def-
icits in brain regions associated with HD symptomatology.
Significance: Combining global- and microstate analyses can be useful for a better understanding of pro-
gressive brain deterioration in HD.
 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Huntington’s disease (HD) is an autosomal-dominant trinu-
cleotide repeat disorder leading to severe neurologic, psychiatric,
and cognitive symptoms. Its core pathology is caused by a
pathologic elongated gene, which results from a base triplet elon-
gation (CAG) on chromosome 4. This gene produces a protein
called Huntingtin, which leads to neural apoptosis especially in
the striatum. Typically, first symptoms of HD appear between the
ages of 30–50. Following disease onset, patients usually have a
remaining life expectancy of 10–15 years (Roos, 2010, Walker,
2007). Deterioration of executive functions, short-term memory
and visuo-spatial functioning are followed by the onset of subcor-
tical dementia in later disease stages (Kirkwood et al., 2000).
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Disease conditions can be regarded as gross altered states
within which shorter altered or aberrant states are embedded
(Lehmann et al., 1987). Electroencephalography (EEG) is an appro-
priate method for the investigation of global states and due to its
very high time resolution it is also perfectly suited for the study
of the briefer states (microstates) embedded therein. EEG fre-
quency spectra and source localization analyses have been used
in previous HD research (for a review, see Piano et al., 2017). The
most consistent findings were a decreased alpha and increased
delta and theta frequency band activity. In order to better under-
stand the brain electric changes associated with the complex
symptomatology of HD, the present study compared a group of
un-medicated HD patients to a group of healthy controls using
EEG measures of both global states and microstates.
Global states can be described using measures of dimensional
complexity. These are indicators of the number of independent
brain processes active in the brain (Wackermann et al., 1993)
and have for example been applied to describe gross states such
as sleep stages (Szelenberger et al., 1996b). Global states differ
between normal healthy controls and depressed (Szelenberger
et al., 1996a) and schizophrenic patients (Saito et al., 1998) and
have been proposed as measures of brain maturation (Stam et al.,
2000). In the present study, we chose omega complexity
(Wackermann, 1996) as a first measure to describe the global state
of HD patients. Informally, omega complexity takes the eigenval-
ues of the covariance of brain activity measures from/with scalp
EEG or cortical activity signals and calculates the number of inde-
pendent sources. The detailed calculation procedure and the justi-
fication for its interpretation can be found in (Wackermann, 1996,
Wackermann and Allefeld, 2009). Omega complexity has been
studied in other disease conditions. It was increased in schizophre-
nic (Irisawa et al., 2006, Saito et al., 1998) and Alzheimer patients
(Czigler et al., 2008, Yoshimura et al., 2004) compared to healthy
controls.
We selected a connectivity measure, global lagged connectivity,
as a second measure to describe the global state of HD. While com-
plexity measures approximate the number of functionally inde-
pendent system units, connectivity measures assess the
cooperativity between system units. Thus, both measures are indi-
cators for dissociation between brain areas. Connectivity measured
as coherence was reported to be increased as well as decreased in
schizophrenic patients, with a tendency for decreased coherence in
medication-naive, younger, first episode patients (see Lehmann
et al., 2014). Coherence was reduced in patients with Alzheimer’s
disease (e.g. Wang et al., 2014) and in disorders related to depres-
sion (Varlamov and Strelets, 2012).
To study the finer-grained aberrations or processing steps
embedded in the underlying global state, a microstate analysis
was performed. The EEG can be looked at as electric potential dis-
tributions on the head surface (‘scalp maps’) at each moment in
time. The EEG microstate analysis searches for scalp maps that
show quasi-stable electric potential distributions over prolonged
periods of time, called ‘microstates’ (Lehmann et al., 1987,
Lehmann et al., 1998). In using the EEG’s very high time resolution,
the microstate analysis reveals microstate durations typically in
the range of 60–120 milliseconds.
Different scalp potential distributions must have been gener-
ated by different spatial distributions of neuronal electric activity
in the brain. Therefore, it is reasonable to assume that different
microstates embody different types of information processing.
EEG microstates have been referred to as putative ‘atoms of
thought and emotion’ (Lehmann, 1990, 2013). Several classes of
microstates have been identified (e.g. Koenig et al., 2002, Michel
and Koenig, 2018). In spontaneous resting state EEG, typically four
classes of microstates are found (Michel and Murray, 2012) that
are usually labelled A, B, C, and D.
The microstates of the different classes can be described using
parameters such as their number of occurrences, how much time
they cover and their mean duration (see methods Section 2.3.3
below). These parameters typically differ between different states
and task conditions. Alterations of the microstate parameters have
been reported for different microstate classes in normal states of
consciousness (non-REM sleep - all classes: Brodbeck et al., 2012,
modalities of thinking- all classes: Milz et al., 2016, personality
characteristics - classes B and C: Schlegel et al., 2012) (self-
related/unrelated thoughts, mental arithmetic - classes B, C and
D: Bréchet et al., 2019), altered states of consciousness such as
meditation (class B: Faber et al., 2005) (all classes: Zanesco et al.,
2019) and hypnosis (classes A, C, and D: Katayama et al., 2007),
but also disorders like schizophrenia (all classes: Andreou et al.,
2014, Irisawa et al., 2006, Kindler et al., 2011, Koenig et al., 1999,
Lehmann et al., 2005, Strelets et al., 2003), euthymic bipolar disor-
der (class A: Damborská et al., 2019) and fronto-parietal dementia
(class C: Nishida et al., 2013). See also Khanna et al. (2015) for a
review. Accordingly, the microstate analysis seems especially
promising for detecting differences in attention-related,
mentation-related and reality-testing related processing.
In addition to the measures of brain-electric activity, cognitive
and behavioural symptoms as well as performance of HD patients
were probed with the Unified Huntington’s Disease Rating Scale
(UHDRS, Huntington study group, 1996) and proven cognitive
tests.
Based on the findings briefly reviewed above we deducted the
following hypotheses:
I) HD patients display significantly altered global characteris-
tics (increased omega complexity and decreased global
lagged connectivity) in comparison to healthy controls.
II) HD patients show significant aberrations of all four micro-
state classes (A, B, C, D) when compared to healthy controls.
III) Aberrations of microstate classes correlate significantly with




EEG data of 20 un-medicated HD patients with the genetic diag-
nosis of HD and of 20 healthy, age, and gender matched controls
were available for the present study. The investigation was carried
out in accordance with the ethical standards put forth in the Hel-
sinki Declaration. The Ethics Committee of the Medical University
of Graz, Austria approved this study (Project No. 31-317ex18/19).
The patient group consisted of 11 males and 9 females (mean
age: 41.37 years, SD = 9.15 years). All patients fulfilled the criteria
for the International Classification of Diseases, Tenth Revision
(ICD-10, World Health Organization, 1993) diagnoses G 10 and F
02.2. The control group consisted of 20 drug-free (age- and sex-
matched) healthy controls (11 males, 9 females; mean age:
41.00 years, SD = 11.64 years), that had been recruited by adver-
tisements. Controls displayed no physical, neurological or mental
illness. Control data had been stored in a data pool.
HD stages (severity) were graded according to Shoulson’s clini-
cal stages (Shoulson and Fahn, 1979). At stage 1, patients clinically
show minimal impairment and function at their usual level; at
stage 5 patients are severely affected, suffer from pronounced
motor and cognitive impairment and require institutional care.
Twelve of our patients were in stage 1, 3 patients in stage 2 and
5 patients in stage 3.
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2.1.1. Behavioral data
Apart from the gradation into clinical HD stages mentioned
above, additional behavioral and cognitive variables were assessed
via questionnaires. The UHDRS was used as customary in many HD
centers (Paulsen, 2011). The motor section of the UHDRS
(Huntington Study Group, 1996) was applied to probe for motor
function disturbances. The Stroop Interference Test (Stroop, 1935,
1992) with color, word and interference subtests, and the Verbal
Fluency test (VF, Benton et al., 1994) were served to screen execu-
tive functions. The Stroop test measures conflict resolution and
inhibition of prepotent responses, and the VF test assesses inter-
nally guided word search and production necessitating the sup-
pression of retrieval/production of inappropriate words and
output monitoring. German versions of the Stroop and VF tests
were used. The Symbol Digit Modality Test (SDMT, Smith, 1968,
1982) was used to assess information processing (attention, per-
ceptual speed, motor speed and visual scanning) and the Mini–
Mental State Examination (MMSE, Folstein et al., 1975) to screen
for signs of dementia.
2.2. Data recording
The recordings of all participants consisted of a nineteen-
channel EEG. The electrode placement was based on the interna-
tional 10–20-system: Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4,
T4, T5, P3, Pz, P4, T6, O1 and O2. All electrodes were referenced
against averaged mastoids. The data were recorded with a Nihon
Kohden 4421 G polygraph. Participants had been kept alert by
the technician with a tapping sound whenever drowsiness patterns
appeared in the record.
2.3. Data analysis
2.3.1. Data preprocessing
From the vigilance controlled task-free resting EEG data,
artifact-free epochs were selected after minimizing ocular artifacts
by regression analysis in the time domain using an automatic arti-
fact identification method (Anderer et al., 1992) and after subse-
quent visual inspection for remaining artifacts.
The following preprocessing steps were applied to the data in
view of the microstate analysis and their compatibility with the
global state analysis. The available 19-channel artifact-free EEG
data were segmented into 2-s epochs. For the patient group, there
was an average of 28.7 artifact-free 2-second epochs available
(SD = 16.2; range: 8–62) per patient. For the control group, 12
artifact-free 2-second epochs were available per participant from
the data pool, for which only the first 12 artifact-free epochs had
been selected. The available data were then re-referenced to the
average reference and FFT-filtered between 2–20 Hz, as commonly
applied for microstate analyses (see Michel and Koenig, 2018). In
order to stay compatible with the microstate analysis, the global
state analyses were performed with the same broad band.
2.3.2. Global state analysis
The global or background states in HD patients and normal,
healthy controls were assessed using a dimensionality and a con-
nectivity measure.
Rather than computing dimensionality and connectivity on
scalp-recorded potential differences (Chella et al., 2017, Lehmann
et al., 2006, Marzetti et al., 2007), these measures were estimated
from intracortical signals using exact low resolution electromag-
netic tomography (eLORETA; Pascual-Marqui, 2007a). eLORETA
uses a solution space of 6239 voxels. In order to obtain an estimate
for the global dimensionality and connectivity, 19 regions of inter-
est (ROIs) were used. Each ROI was defined by the single underly-
ing cortical grey matter voxel closest to each of the 19 electrode
positions of the 10–20 system. Using one voxel for the definition
of the ROIs is adequate due to the smoothness constraint of the
LORETA solution. The following global measures are based on these
19 eLORETA ROI signals, band-pass filtered from 2-20 Hz, com-
puted for each participant in each group.
Both omega complexity and global lagged connectivity were
computed using an implementation of the respective algorithms
(lagged connectivity: Pascual-Marqui, 2007b, Pascual-Marqui
et al., 2011) (omega complexity: Wackermann, 1996, 1999,
Wackermann and Allefeld, 2009) in the eLORETA software package
(version 2020–04-14, freely available at https://www.uzh.ch/key-
inst/loreta.htm).
Omega complexity (Wackermann, 1996, 1999, Wackermann
et al., 1993) is a single-value measure that assesses the dimen-
sional complexity of multi-channel signals. In effect, it is a global
measure that gives an approximation to the number of indepen-
dently active processes in the brain. In the present study, omega
complexity computations are based on the complex valued covari-
ances between signals in the frequency domain, more specifically,
on the Hermitian cross-spectral matrices, as performed, e.g. in
Molnár et al. (2006). Thus, this generalization takes into account
phase information, i.e. both instantaneous and lagged dependen-
cies between brain processes.
As previously mentioned, connectivity computations in this
study are based on the estimated cortical source signals. However,
these signals are affected by volume conduction and low spatial
resolution, which are known to produce unduly high coherence
values with zero-lag. This means that the estimated cortical signals
consist of an instantaneous mixture of the actual signals. One early
remedy for this problem was proposed by (Nolte et al., 2004),
which retains only the imaginary part of the coherence. In this pre-
sent study, a related but different measure is used, namely the
‘‘lagged coherence”, which has been demonstrated to be invariant
to the instantaneous mixture of signals (Pascual-Marqui et al.,
2018). The ‘‘global lagged coherence” defined in (Pascual-Marqui,
2007b) is intended as a single-value measure for the global connec-
tivity (lagged connectivity) characterizing the underlying global
state of HD patients and controls.
2.3.3. Microstate analysis
The EEG microstate analysis methodology has recently been
reviewed by Michel and Koenig (2018). Following the classical pro-
cedure for microstate computation, in a first step the global field
power (GFP, Lehmann and Skrandies, 1980) curve was computed
in each 2-s epoch. All potential maps at times of maximal GFP
(‘GFP-peaks’) were selected across all epochs per participant. The
GFP-peak maps represent potential maps at times of optimal
signal-to-noise ratio and around GFP-peaks map topographies
remain stable while they change in GFP-troughs (Koenig et al.,
2002). Therefore, in a second step only these GFP-peak maps were
then fed into a modified k-means clustering algorithm (Pascual-
Marqui et al., 1995) that uses Global Map Dissimilarity (Lehmann
and Skrandies, 1980) as clustering criterion and that produced
for each participant 4 individual model maps (‘microstate classes’)
that best explained the variance in the data. The use of a cross val-
idation criterion has previously shown that 4 model maps consti-
tute an optimal solution (Koenig et al., 1999). In a third step, the
individual model maps of all the participants of each group (pa-
tients and controls) were used to compute mean group model
maps using a permutation algorithm that maximizes the common
variance over participants (Koenig et al., 1999). The two sets of four
group model maps (patients and controls) were then used to com-
pute a set of 4 grand mean model maps (classes) using the same
procedure. In order to remain comparable to previous publications,
these grand mean classes were then related in a fourth step to the
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4 normative microstate classes published by Koenig et al. (2002)
and were labeled accordingly as microstate classes A, B, C and D.
In a final step, all GFP peak maps were attributed to one of the
four grand mean classes. A ‘microstate’ is defined by consecutive
GFP-peak maps of the same class. The start of each microstate is
defined by the midpoint between the last GFP-peak map of the pre-
ceding microstate and the first GFP-peak map of the current micro-
state, and analogous for the end of each microstate. Since the start
of the first microstate and the end of the last microstate of each 2-s
epoch is unknown, the first and the last microstates were omitted
for the computation of the typical microstate parameters: occur-
rence, coverage over time and duration. The ‘occurrence’ is the
mean number of occurrences of a certain class per second across
all epochs. The ‘coverage’ is the mean percentage of time covered
by a certain microstate class across all occurrences of that class
per second across all epochs. The ‘duration’ is the mean duration
of a certain microstate class of all its occurrences per second across
all epochs.
The microstate analysis was computed using keypy, an open
source python script library developed at the KEY Institute for
Brain-Mind research, Zurich (Milz, 2016, Milz et al., 2016), which
is freely available from: https://github.com/keyinst/keypy.
2.3.4. Correlation analyses
In the patient group, Pearson correlations were computed
between the behavioral and cognitive data (i.e. the stage of the dis-
ease, the scores on the MMSE, the motor UHDRS, the SDMT, the
Stroop tests and the VF test) and the connectivity and complexity
measures as well as the microstate parameters. Further, the micro-
state parameters and the connectivity and complexity measures
were correlated. The significance threshold was at uncorrected
p < 0.05 and the effect sizes for the correlation coefficients (med-
ium: >0.3, large: >0.5; see e.g. Cohen, 1988, Poldrack et al., 2008)
are also reported.
2.3.5. Statistical analyses
A manova was computed for each microstate parameter (cover-
age, occurrence and duration) to compare groups (HD patients and
matched controls) using microstate class as repeated measure.
Post-hoc unpaired t-tests for unequal variance were used to untan-
gle significant interaction (class  group) effects, i.e. between
groups per class.
A one-way anova was computed to compare groups (HD
patients and matched controls) for global lagged connectivity and
omega complexity as dependent variables. Post-hoc unpaired t-
tests for unequal variance were used to untangle main effects.
3. Results
3.1. Behavioral data
Our HD patient group consisted of mild to moderate stage
patients (Shoulson’s clinical stages 1–3; Shoulson and Fahn,
1979). All patients were symptomatic and revealed impairments
in one or more of the cognitive and behavioral tests. The mean
scores and standard deviations were as follows: UHDRS motor sec-
tion: 22.05 (19.50); MMSE: 21.25 (5.08); Stroop color: 53.75
(22.07); Stroop word: 59.35 (25.94); Stroop interference: 26.65
(10.79); VF test: 22.85 (10.10); SDMT: 24.85 (13.44). Lower test
scores generally indicate impairment, except for the UHDRS motor
score where a higher score means higher impairment.
3.2. Global state analyses
Global state measures showed a significant main effect in the
anova group comparisons (Table 1a). Post-hoc t-tests showed that
only global lagged connectivity differed between controls and HD
patients, while omega complexity did not. Patients showed a sig-
nificantly lower (0.42 (0.23)) global lagged connectivity than con-
trols (0.70 (0.37), p = 0.007) (Table 1b).
Correlations with the stage of the disease within patients
showed no correlation for global lagged connectivity, but a positive
correlation at uncorrected p < 0.05 for omega complexity (r = 0.45)
with a medium effect size (>0.3), omega complexity thus increas-
ing with the severity of the disease.
3.3. Microstate analysis
The four grand mean microstate classes (Fig. 1) extracted from
the EEG were very similar to the 4 classes from the normative data-
base (Koenig et al., 2002).
The manovas did not show any significant group effects for the
microstate parameters independent of class, but revealed signifi-
cant interaction-effects of class * group for both coverage and
occurrence (p < 0.05) and a trend for duration (p = 0.087;
Table 2a). The post-hoc unpaired t-tests for the microstate param-
eters revealed those classes for which the parameters significantly
differed between the two groups (Table 2b). In HD patients com-
pared to their matched healthy controls, microstates of classes A
and B had higher coverage (p < 0.05) and a trend of higher duration
(p < 0.10). Microstate class C had lower occurrence (p < 0.05) and a
trend of lower coverage (p < 0.10). Microstate class D had lower
coverage and occurrence (p < 0.05). Table 3 illustrates the direc-
tional changes of the microstate parameters from controls to HD
patients for all comparisons.
3.3.1. Correlations between global state and microstate measures and
the behavioral and cognitive data
Table 4 depicts the results of the correlation analyses between
the behavioral data and global state measures with the microstate
parameters (Table 4a) and the behavioral data with the global state
measures (Table 4b). Scatterplots of all significant correlations are
illustrated in Supplementary Figures S1–S3.
There were no significant correlations between global lagged
connectivity and any of the behavioral or cognitive scores. Omega
complexity on the other hand showed a significant positive corre-
lation with the stage of the disease and significant negative corre-
lations with the MMSE, the Stroop interference and the VF tests.
The behavioral and cognitive scores revealed some significant
correlations with the microstate parameters. The stage of the dis-
ease (severity) was positively correlated with microstate class A
coverage and occurrence as well as negatively correlated with
microstate class C coverage and duration.
The motor UHDRS scores showed merely a significant positive
correlation with class A coverage.
The MMSE scores were not correlated with the microstate
parameters.
Both the scores on the Stroop tests and the SDMT were nega-
tively correlated with class A occurrence (and coverage for the
Stroop word test) and positively correlated with class C coverage
(except for Stroop interference) and duration.
The VF test scores were not correlated with the microstate
parameters.
The behavioral and cognitive scores all correlated significantly
with the stage of the disease (Table 5), indicating a worsening in
the tests with increasing HD severity.
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3.3.2. Correlations between microstate and global state measures
The two right columns of Table 4a list all correlations between
global and microstate measures in the patient group.
Global lagged connectivity was negatively correlated with
microstate class A occurrence and positively correlated with
microstate class C duration.
Omega complexity did not show any significant correlations
with the microstate parameters.
4. Discussion
Considering the progressive widespread neuronal death and the
complex symptomatology consisting of motor, cognitive and psy-
chiatric symptoms of HD, we expected wide-ranging differences
of global- and microstate EEG measures in un-medicated HD
patients compared to healthy age and gender matched controls.
As expected, we observed extensive changes in all EEG measures
in HD patients. In the patient group, we additionally found correla-
tion patterns between cognitive and behavioral data and EEG
measures.
4.1. Global state results
The two global state measures showed interesting results. On
the one hand, global lagged connectivity was lower in patients
than controls, while omega complexity did not differ. On the other
hand, omega complexity showed a positive correlation with the
stage of the disease while global lagged connectivity did not.
Omega complexity approximates the number of functionally inde-
pendent system units while global lagged connectivity is a mea-
sure of the interaction between system units. HD thus seems
characterized by underlying global states showing an increasing
number of independent processes with increasing severity of the
disease and significantly less cooperation between brain areas
independent of the severity of the disease, indicating an increased
dissociation in HD.
While all correlations between omega complexity and the
behavioral and cognitive test scores revealed at least medium
(r > 0.3) effect sizes, only those for the MMSE, the Stroop interfer-
ence test and the VF test reached significance. As all behavioral and
cognitive tests correlated significantly with HD stage showing that
the test performance worsened with the progression of the disease,
these results indicate that the worsening of the test performance
was associated with increasing dimensionality, i.e. increased
dissociation.
4.2. Microstate results
As expected, the EEG microstate analysis revealed changes of
the parameters of all 4 microstate classes in patients suffering from
HD compared to healthy, age and gender matched controls. These
results suggest that the symptomatology of HD is reflected in
abnormal steps of information processing. The main findings were
an increase in one or more parameters for microstate classes A and
B and a decrease for classes C and D. The fact that all four micro-
state classes are affected by HD may reflect the complex symp-
tomatology and neuronal deterioration of this disease.
The functional significance of the four microstate classes and of
their interplay is not yet fully established but has lately been the
target of several studies (Britz et al., 2010, Custo et al., 2017,
Milz et al., 2016, Pipinis et al., 2016, Seitzman et al., 2017). In the
following paragraphs, our results are discussed in the light of what
is known about the functional significance of the different micro-
states classes.
4.2.1. Alterations of microstate classes a and B
In HD patients, we observed a significantly increased coverage
and a trend towards an increased duration of both classes A and B.
Increased coverage of class A microstates was reported in indi-
viduals at high risk of psychosis (Andreou et al., 2014) and in
patients with panic disorder (Kikuchi et al., 2011). It has been pro-
posed that an increase in class A prominence could be a predictor
of psychotic transition or an unspecific indicator of anxiety
(Andreou et al., 2014). With increasing severity of HD, both psy-
chotic symptoms (e.g. delusions) and anxiety symptoms (e.g. para-
noia) emerge (Kirkwood et al., 2001). Thus, our results seem in line
with one or both of these observations.
Class A coverage and occurrence were increased in patients
with Parkinson’s disease (PD) and correlations linked class A occur-
rence to motor function (Chu et al., 2020). These results only partly
match our own. We also found a trend towards increased class A
coverage, but we found no difference in occurrence compared to
Table 1a
Results of one-way anova group comparison (Huntington’s Disease patients versus
controls) for global state measures (global lagged connectivity and omega complex-
ity) as dependent variables.
Wilks’ Lambda df F p-value
group 0.813 2.0, 37.0 598.724717 0.022
Significant p-values at p < 0.05 are bolded.
Table 1b
Global state group comparisons: means, standard deviations and p-values for
unpaired post-hoc t-tests.
Global lagged connectivity Omega complexity
mean (sd) mean (sd)
HD patients 0.42 (0.23) 4.72 (0.90)
controls 0.70 (0.37) 4.47 (0.92)
p-value 0.007 0.381
HD: Huntington’s Disease; significant p-values at p < 0.05 are bolded.
Fig. 1. The grand mean model maps of the four microstate classes. Equipotential area maps are shown. Semi-schematic electrode array in inset. Head seen from above,
nose up, left ear left. The isopotential contour maps show the (arbitrarily assigned) areas of opposite polarity in black and white (normalized voltage values). A-D: microstate
class labels.
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controls in our HD patients. Also, while Chu et al. (2020) reported
decreasing occurrence with increasing deterioration of motor func-
tion, we found increasing coverage with increasing deterioration of
motor function. These results suggest a relation of class A to motor
function, but they also seem to imply differences between HD and
PD patients.
Microstate class A coverage increases were linked to apathy in
schizophrenic patients (Giordano et al., 2018). More precisely, avo-
lition apathy correlated positively with class A coverage and the
authors suggested that the motivational deficits might be related
to underlying sensory processing abnormalities (Giordano et al.,
2018). Apathy is considered a very common feature of HD
(Camacho et al., 2018). The precise characteristics of apathy in
HD are not yet clearly defined, validated assessment tools in HD
are still missing and studies are scarce (Camacho et al., 2018).
While the link of increased class A coverage to apathy is interest-
ing, it remains hypothetical in the present dataset, as apathy was
not assessed in our patients.
Class B alterations have been reported in different normal,
altered and diseased states of consciousness. Class B decreases in
all parameters were reported in light hypnosis (Katayama et al.,
2007), the duration was decreased in schizophrenic patients
(Lehmann et al., 2005, Nishida et al., 2013), the coverage was
increased in schizophrenic patients (Andreou et al., 2014), occur-
rence and coverage were increased in believers in paranormal phe-
nomena as compared to skeptics (Schlegel et al., 2012) and
duration was increased in very experienced meditators during
deep meditation (Faber et al., 2005). While these findings are too
inconsistent to draw any conclusions, a very recent study (Chu
et al., 2020) reported results that seem more promising for the
interpretation of the present findings. They found increased class
B coverage in patients with PD and that increased class B duration
correlated with cognitive performance. We also found increased
class B coverage and a trend towards increased duration, which
could thus be related to the hampered cognitive performance we
see in our HD patients.
Several studies aimed to associate microstate classes A and B
with modality-specific, visual or verbal / phonological processing
(Britz et al., 2010, Custo et al., 2017, Milz et al., 2016, Seitzman
et al., 2017). Recent results suggest that class A prominence was
increased when alpha inhibition was increased over left posterior
language related areas, and class B prominence was increased
Table 2a
Results of manova group comparisons (Huntington’s Disease patients versus controls) for each microstate parameter (coverage, occurrence and duration) with microstate classes
(A, B, C and D) as repeated measure.
Wilks’ Lambda df F p-value
coverage
class 0.362 3.0, 36.0 21.128 0.000
class * group 0.645 3.0, 36.0 6.604 0.001
occurrence
class 0.381 3.0, 36.0 19.500 0.000
class * group 0.638 3.0, 36.0 6.814 0.001
duration
class 0.421 3.0, 36.0 16.496 0.000
class * group 0.835 3.0, 36.0 2.368 0.087
Significant p-values at p < 0.05 are bolded; trends at p < 0.10 are underlined.
Table 2b
Microstate parameters per microstate class: means, standard deviations and p-values of unpaired post-hoc t-tests.
class A class B class C class D
mean (sd) mean (sd) mean (sd) mean (sd)
coverage
controls 19.30 (5.94) 22.98 (4.09) 34.65 (5.37) 23.07 (6.39)
HD patients 23.53 (6.34) 28.13 (5.48) 30.29 (8.30) 18.09 (4.24)
p-value 0.036 0.002 0.057 0.007
occurrence
controls 3.06 (0.98) 3.44 (0.58) 4.36 (0.60) 3.48 (0.54)
HD patients 3.34 (0.79) 3.76 (0.69) 3.78 (0.74) 2.85 (0.67)
p-value 0.320 0.122 0.009 0.003
duration
controls 63.75 (10.53) 67.75 (13.38) 80.31 (14.13) 66.28 (14.43)
HD patients 70.60 (13.53) 75.44 (12.34) 80.27 (15.67) 64.30 (9.63)
p-value 0.082 0.066 0.994 0.612
HD: Huntington’s Disease; significant p-values at p < 0.05 are bolded; trends at p < 0.10 are underlined.
Table 3
Directional changes of microstate parameters between groups per microstate class.
from controls to un-medicated HD patients
A B C D
coverage % % & &
occurrence - - & &
duration % % - -
A-D: microstate class labels; HD: Huntington’s Disease; bold and larger arrows: p < 0.05; standard arrows: p < 0.10 (trend); - no change.
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when alpha inhibition was increased over right posterior visuo-
spatial related areas (Milz et al., 2017). Consequently, our observed
increase in class A and B microstate prominence in HD might
reflect an increased inhibition and thus disturbance of both verbal
and visual functioning in HD patients. This would be in line with
the worsening of the performance in the cognitive tests seen in
HD patients.
4.2.2. Alterations of microstate classes C and D
Class C microstates have been associated with activity in two
important hubs of the default mode network (DMN, Raichle
et al., 2001): the anterior cingulate cortex (ACC) and the posterior
cingulate cortex (PCC) (Pascual-Marqui et al., 2014). An earlier
study reported class C microstate correlations with positive blood
oxygen level dependent (BOLD) signals in the ACC, the bilateral
frontal gyri and the right insula (Britz et al., 2010), regions belong-
ing to the resting state network 6 in Mantini et al. (2007). These
areas overlap with the saliency network and were linked to subjec-
tive interoceptive-autonomic processing. Class C processing thus
possibly is involved in the integration of interoceptive information
with emotional salience to form a subjective own body representa-
tion (Britz et al., 2010).
In the present study, un-medicated HD patients showed
reduced occurrence and a trend for reduced coverage of class C
microstates. Also, the coverage and duration correlated negatively
with the stage of the disease. This is in line with results showing
that cell loss in the ACC correlates with HD symptomatology dur-
ing the course of the disease (Thu et al., 2010). Considering these
findings, one might speculate that in HD patients the progressive
motor decline and failing emotional salience attribution is partly
related to an impaired class C processing. This could be due to
the increasing attention demanding aspects of the coordination
and involuntary movement related symptoms of the disease when
it progresses to advanced stages or due to cell loss during the
course of the disease. Interestingly, during light hypnosis, class C
microstates also show decreased prominence, possibly due to the
increased inward-directed attention to bodily perceptions
(Katayama et al., 2007). This is in line with Pipinis et al. (2016)
who reported a negative correlation of class C microstate coverage
with experienced somatic awareness.
Class D microstates in HD patients were characterized by a gen-
eral reduction of coverage and occurrence compared to controls.
Reduced microstate parameters have been reported in several
studies. Schizophrenia studies reported reductions in one
(Kindler et al., 2011, Nishida et al., 2013), two (Kikuchi et al.,
2007) or all three (Tomescu et al., 2014) class D microstate param-
eters. A meta-analysis (Rieger et al., 2016) confirmed both a short-
ened class D duration and a reduced class D coverage in
schizophrenia. During deep hypnosis class D duration was short-
ened and coverage reduced (Katayama et al., 2007). During non-
REM sleep, class D duration was prolonged but its occurrence
was reduced (Brodbeck et al., 2012). Together these studies suggest
that all three microstate parameters can be affected in reality
remote states, most often reflected in a reduction of the
corresponding parameters. Based on these findings, it has been
suggested that class D microstates reflect processes involved in
reality testing (Milz et al., 2016, Rieger et al., 2016). The actual con-
tribution or involvement of each parameter or the details of their
interplay regarding their role in reality testing are still unclear.
Nevertheless, the literature suggests that some or all microstate
class D parameters are modulated by reality testing processes.
The reduced prominence of class D microstates in HD patients
could thus indicate a reduced activation of processes associated
with reality testing.
Table 4




















class A 0.49 0.29 0.46 0.53 0.42 0.33 0.42 0.35 0.32 0.33
class B 0.14 0.21 0.01 0.03 0.36 0.05 0.23 0.21 0.11 0.20
class C 0.57 0.21 0.37 0.53 0.62 0.41 0.56 0.18 0.43 0.12
class D 0.19 0.25 0.06 0.29 0.11 0.25 0.18 0.09 0.21 0.01
Occurrence
class A 0.51 0.28 0.36 0.49 0.55 0.44 0.47 0.38 0.57 0.27
class B 0.22 0.08 0.02 0.01 0.40 0.23 0.25 0.01 0.33 0.01
class C 0.32 0.07 0.21 0.30 0.21 0.05 0.20 0.07 0.07 0.01
class D 0.23 0.30 0.06 0.29 0.23 0.36 0.27 0.22 0.25 0.07
Duration
class A 0.11 0.02 0.23 0.16 0.04 0.09 0.03 0.02 0.14 0.07
class B 0.04 0.19 0.05 0.04 0.01 0.20 0.02 0.25 0.24 0.22
class C 0.51 0.28 0.32 0.48 0.69 0.58 0.62 0.25 0.53 0.21
class D 0.09 0.17 0.02 0.07 0.24 0.28 0.18 0.28 0.11 0.17
b) Glob. lag.
connectivity
0.17 0.17 0.14 0.29 0.36 0.36 0.28 0.26
Omega complexity 0.45 0.46 0.39 0.38 0.43 0.55 0.43 0.59
HD: Huntington’s Disease, MMSE: Mini–Mental State Examination, UHDRS: Unified Huntington’s Disease Rating Scale; significant correlation coefficients at uncorrected
p < 0.05 are bolded; a single underline indicates a medium effect size (r > 0.3), a double underline a strong effect size (r > 0.5).
Table 5
Pearson Product Moment correlations between behavioral and cognitive scores and Huntington’s Disease stage (severity) for the Huntington’s Disease patient group (N = 20).
MMSE UHDRS (motor) Stroop (word) Stroop (color) Stroop (interf.) Symb. Digit Verbal Fluency
HD stage 0.48 0.64 0.65 0.82 0.70 0.66 0.46
HD: Huntington’s Disease, MMSE: Mini–Mental State Examination, UHDRS: Unified Huntington’s Disease Rating Scale; all correlations were significant at uncorrected
p < 0.05; a single underline indicates a medium effect size (>0.3), a double underline a large effect size (>0.5).
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As mentioned above, Milz et al. (2017) reported that the fre-
quency band-wise source localization differences between the
microstate classes are predominantly defined by the alpha activity;
also, classes C and D both showed highest underlying alpha activ-
ity. Most EEG studies reviewed by Piano et al. (2017) reported a
decrease in alpha activity in HD, which appears to be a trait marker
of HD (Painold et al., 2010, 2011). Our reported decrease in class C
and D prominence is thus in line with these observations.
4.2.3. Microstate interactions
In general, it is plausible to assume that the interplay between
themicrostate classes is crucial for the constitution of different nor-
mal, abnormal and diseased states of consciousness. In a microstate
study on hypnosis (Katayama et al., 2007), light hypnosis only
showed a decreased occurrence and coverage of class C compared
to restingwhile in deep hypnosis occurrence and coverage of class A
was increased and duration and coverage of class D decreased. HD
patients also showed an increase of class A coverage, a decrease of
class C occurrence and a decrease of class D coverage and occur-
rence. HD thus shares some characteristics of both light and deep
hypnotic conditions. Hypnosis has been characterized as focused
attention, enhanced somatic and emotional control, and lack of
self-consciousness (Jiang et al., 2016). It has also been argued that
hypnosis is characterized by a functional dissociation of conflict
monitoring and cognitive control processes (Egner et al., 2005). As
mentioned before, ACC-cell loss correlated with HD symptomatol-
ogy (Thu et al., 2010) and in a functional neuroimaging study the
ACCwas less recruited in individuals highly susceptible to hypnosis
(Cojan et al., 2015), which could account for HD patients reflecting
similar microstate patterns as people in hypnotic states.
Cognitive decline in patients with Alzheimer’s disease corre-
lated positively with a general microstate duration decrease
(Strik et al., 1997). In contrast, we found a trend towards increased
class A and class B durations in our HD patients, which could be
due to the fact that they were in initial to moderate disease stages.
Cognitive decline has been linked to class C occurrence decreases
and class B duration increases in PD patients (Chu et al., 2020),
which seems in line with our results showing decreased class C
occurrence and a trend towards increased class B duration in HD
patients, thus possibly reflecting the cognitive decline seen in HD
patients. In schizophrenia, class C occurrence increased and class D
duration decreased (Rieger et al., 2016), whereas in our initial to
moderate HD patients we observed decreases in class C occurrence
and class D coverage and occurrence. Psychotic symptoms pre-
dominantly occur in late stages of HD - it is not known however
whether late stage HD patients would show a pattern similar to
patients with schizophrenia. Also, the four microstate classes are
typically alternating and the microstate syntax – i.e. the concate-
nation of microstates of different classes – is known to differ in dif-
ferent normal and pathological states (Lehmann et al., 2005,
Schlegel et al., 2012). Therefore, the interplay of the microstate
classes might be related to behavioral effects and clinical symp-
toms in HD patients.
The general pattern of our results is very similar to that of PD
patients reported by Chu et al. (2020). PD patients also showed
microstate parameter increases for classes A and B and decreases
for classes C and D. These similarities might be due to cognitive
and motor function declines seen in both diseases, while the differ-
ences in which parameters were significantly affected might be
due to the underlying physiological differences between HD and
PD.
4.3. Correlation results
When studying all correlation results as listed in Table 4, a clear
pattern emerges: the highest correlations and the largest number
of significant correlations (at uncorrected p < 0.05 and with med-
ium or large effect sizes) concern microstate class A coverage and
occurrence as well as class C coverage and duration. While the
group comparisons showed that all classes of microstates are
affected by the disease, the correlation results revealed that only
classes A and C are related to the progression of the disease. In gen-
eral, the higher class A prominence and the lower class C promi-
nence, the more advanced the HD symptoms (stage) were and
the worse the performance in the cognitive tests, and also the
higher the dissociation (increased dimensionality) became. Perfor-
mance in the cognitive tests was better (all correlations showed at
least medium effect sizes, 3 were significant), the lower the omega
complexity, which seems to imply increased focused attention for
better performance. Considering that class C prominence
decreased in HD patients suggesting increased attention and
somatic awareness, combined with a class D decrease suggesting
reduced reality testing, one might speculate that the focused atten-
tion needed for good test performance was disturbed by an
increased focus on bodily perceptions and reduced reality testing.
The correlations of class C coverage and occurrence as well as
class A occurrence with SDMT scores fit well into this scheme.
SDMT scores have been shown to correlate with brain areas related
to motor processing, cognitive control, auditory and semantic pro-
cessing as well as visual processing in a structural magnetic reso-
nance imaging study in prodromal HD subjects (Harrington et al.,
2014). This is in line with the function of class C related to saliency
(Britz et al., 2010) and of class A modulating language-related areas
(Britz et al., 2010, Milz et al., 2016) and possibly motor function
(Chu et al., 2020). The SDMT evaluates information processing (at-
tention, perceptual speed, motor speed and visual scanning) and
our results thus show that hampered information processing in
HD is related to an occurrence decrease of class A microstates as
well as a coverage and duration increase of class C microstates.
The ACC and the dorsolateral prefrontal cortex (DLPFC) are
mainly implicated when performing a Stroop task (e.g. Egner and
Hirsch, 2005, Milham et al., 2003). These areas are most likely
reflected by microstate class C (see Custo et al., 2017) which shows
reduced coverage and duration with decreasing Stroop task perfor-
mance in our data. Class A shows increased occurrence and cover-
age with decreasing Stroop task performance in our HD patients.
These results seem to imply disturbed class A and C processing
in HD patients during the solving of the Stroop tasks while classes
B and D are not affected. Hampered memory and executive func-
tions as well as response selection and attention resource alloca-
tion (as measured by the Stroop tasks) are possibly implemented
by hampered functioning of the saliency network (class C, Britz
et al., 2010) and possibly motor preparation mechanisms (class
A, Chu et al., 2020).
We note that while the test scores of verbal fluency showed
basically the same correlational pattern with the microstate
parameters as the other test scores, none of the correlations
reached significance. The reason probably is that speech difficulties
typically occur in later stages of the disease (Kirkwood et al., 2001)
and indeed, our group of early to moderate stage patients showed
on average normal scores. The same can be speculated for the
correlations concerning the UHDRS (motor) test, as again, the pat-
tern is the same, but only the correlation with class A coverage
reaches significance; the exclusion of advanced stage patients with
more severe motor disturbances might have prevented more pro-
nounced correlations. We note though, that all included patients
showed above zero scores, thus presenting at least some motor
symptoms. We also note that we found a possible relation of class
A coverage to motor function, while Chu et al. (2020) reported such
a relation with class A occurrence. More studies are needed to
unravel the functional significance of the different class A parame-
ters in their possible relation to motor function.
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4.4. Limitations
A limitation of the present study is that only medication-free
patients were included. Our participant-pool thus only included
patients with mild to moderate HD stages. This fact limits general-
ization of the findings regarding microstate changes during the
complete progression of the disease.
Another limitation concerns the rather low number of EEG
epochs available in some patients and the therefore possibly low
signal to noise ratio, mostly due to the difficulties inherent in
recording HD patients showing motor symptoms. Also, there was
a significant difference in the number of epochs between patients
and controls which stems from the fact that control data was taken
from a recruited data pool with a fixed number of epochs available.
This discrepancy has been accounted for by using tests for unequal
variances.
A further limitation of this study is the small number of elec-
trodes used, namely 19 electrodes of the 10/20 system. The main
effect that this has with respect to the eLORETA estimated cortical
sources and their dynamics is that there is low spatial resolution,
but with exact localization. A number of studies have provided val-
idation for eLORETA with as little as 28 down to 19 electrodes
(Dierks et al., 2000, Mulert et al., 2004, Pizzagalli et al., 2004, Zum-
steg et al., 2006, Zumsteg et al., 2005).
5. Conclusions
In sum, the present global state results showed that HD is char-
acterized by reduced connectivity and increasing dimensionality
(complexity) with disease worsening, suggesting a dissociation
between brain regions compared to healthy controls. The micro-
state results revealed that HD is characterized by alterations affect-
ing all EEG microstate classes with increased prominence of classes
A and B and decreased prominence of classes C and D. The correla-
tion analyses disclosed that an excess of class A microstates and a
shortage of class C microstates go hand in hand with increasing
severity of the disease and worsening of the performance in cogni-
tive tests, and with global state changes indicative of a stronger
dissociation of specific brain areas with the progression of disease
severity.
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